@humacyte
The Turning Point in Regenerative Medicine
LinkedIn
LinkedIn
X
X
Facebook
Facebook
Humacyte.com
Humacyte.com
Latest Humacyte News
Latest Humacyte News
The Investor Relations website contains information about Humacyte, Inc.'s business for stockholders, potential investors, and financial analysts.
Our Pipeline
Our Pipeline
Nasdaq: HUMA
Nasdaq: HUMA
Humacyte in the News:
Insider: Ukraine Surgeons Use Human Acellular Vessel...
Insider: Ukraine Surgeons Use Human Acellular Vessel...
(Tap to Watch) WRAL: Durham Company Growing Blood Vessels...
(Tap to Watch) WRAL: Durham Company Growing Blood Vessels...
CBS17: Durham Company Working to Develop 'Biovascular Pancreas'...
CBS17: Durham Company Working to Develop 'Biovascular Pancreas'...
A Durham company is working to develop a product that could change the way type 1 diabetes is treated.
Vascular News: Positive Top Line Results Announced From Phase 2/3 Trial
Vascular News: Positive Top Line Results Announced From Phase 2/3 Trial
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
Follow Us:
On LinkedIn
On LinkedIn
Humacyte | 14,960 followers on LinkedIn. Our vision is to be the global leader in engineering regenerative medicine products to save and improve patient lives. | Humacyte, Inc. (Nasdaq: HUMA) is proud to announce that in Dec 2024, FDA granted full approval for our Acellular Tissue Engineered Vessel (ATEV), a first-in-class, universally implantable, bioengineered human vessel for extremity arterial trauma. This approval is a significant milestone in regenerative medicine, offering a new treatment option for patients with severe arterial injuries.See the Prescribing Information, including Boxed Warning: https://bit.ly/4dl5tuL This is the first approval in our bioengineered ATEV Platform where we are continuing to investigate use of our lab-grown tissues and organs to improve the lives of patients and transform the practice of medicine.
On X/Twitter
On X/Twitter
On Facebook
On Facebook
Careers with Humacyte:
Come Work for Us
Come Work for Us
View on mobile
Explore other Linktrees
Sofia Tilbury
@sofiatilbury
BNC Map
@bncmap
Kara Harms
@thewhimsysoul
padmalakshmi
@padmalakshmi
Kaitlyn Johnson
@missynjohnson
Lindsey Baker
@itslindss
royelotis
@royelotis
Halley Kate
@halleykmcg
TJ Palma
@tjpalma
adammgrant
@adammgrant
previous
next
Discover more
See all
@thefathercar
@scottsellsmiddletn
@JojoKibz
@deadsoulkllr
@Fonothaisdelcastilo
@missesmojorisin
@gardenofaethel
@affadxyz_
@gruposcout52
@annalucat
@federacaocatarinensedehipismo
@tlhministries
@HistoriaNG
@meirimassa
@emilymboyorks
@bm2sm
@EmanuelEnNoruega
@todocorneliusklg
@Younes_elkorti
@chabotarchitectureclub
@lefteyevisionz
@Ulovetatsumi
@cheersmagelang
@buburking
@Authorshikhaa
@jordydonations
@KASMUSIC
@thrivinglittlethinkers
@mysterious_breakfast
@stirup2025
@smr.jpg
@hisndherscreations
@kclefs
@SeguraGatinho
@michiamanoalaska
@bookshelfbylina
@ambipar.ambify
@hypniq_jerk
@Tlgli
@vividskinwaxlash
@fisioterapi9
@pov.property
@freetiana
@oror_
@BobMooDairyLLC